FDA Adverse Event Injury Summary report: N

PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM

MDR report key: 969520 · Received December 19, 2007

Report

Report Number
2953144-2007-01268
Event Type
Injury
Date Received
December 19, 2007
Report Date
November 25, 2007
Manufacturer
ABBOTT VASCULAR - VASCULAR SOLUTIONS
Product Code
MGB
PMA / PMN Number
P960043
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED TO ABBOTT VASCULAR; THEREFORE, WE WERE NOT ABLE TO PERFORM A DEVICE ANALYSIS. THE LOT NUMBER WAS NOT PROVIDED; THEREFORE, A DEVICE HISTORY RECORD REVIEW COULD NOT BE PERFORMED. LITERATURE SEARCH ARTICLE: NEW ENGLAND SOCIETY FOR VASCULAR SURGERY 2007; 45: 1095-1101. WRITTEN BY W. ANTHONY LEE, MD, TITLED "TOTAL PERCUTANEOUS ACCESS FOR ENDOVASCULAR AORTIC ANEURYSM REPAIR ("PRECLOSE" TECHNIQUE)".

Description of Event or Problem · 1

DEVICE MALFUNCTION: NONE. TIME OF SYMPTOMS/AE: AFTER VESSEL CLOSURE (27 DAYS). SYMPTOMS/AE: PSEUDOANEURYSM. THIS WAS NOTED THROUGH A PERIODIC ARTICLE REVIEW THAT ASSESSED TOTAL PERCUTANEOUS ACCESS FOR ENDOVASCULAR AORTIC ANEURYSM REPAIR. A PRECLOSE TECHNIQUE WAS USED INVOLVING DEPLOYMENT OF THE PROGLIDE DEVICE BEFORE PROCEDURAL SHEATH INSERTION. A TOTAL OF 559 PROGLIDE DEVICES WERE USED TO CLOSE 279 FEMORAL ARTERIES; THERE WERE 16 FAILURES, MAINLY DUE TO OBESITY, DEVICE MALFUNCTION, SEVERE CALCIFICATION AND FAULTY ARTERIAL PUNCTURES. 27 DAYS AFTER THE VESSEL CLOSURE PROCEDURE OF THE COMMON FEMORAL ARTERY (CFA) WITH THE PROGLIDE, A MYCOTIC PSEUDOANEURYSM WAS NOTED REQUIRING SURGICAL REPAIR USING AN AUTOGENOUS FEMORAL VEIN DUE TO NECROTIZING ARTERITIS IN THE CFA. INFORMATION REGARDING THE CAUSE FOR THE PSEUDOANEURYSM WAS NOT SPECIFIED. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM MGB ABBOTT VASCULAR - VASCULAR SOLUTIONS NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK YR Hospitalization| R